High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy | |
Wang, Chunyu; Fu, Xiaolong; Cai, Xuwei; Wu, Xianghua; Hu, Xichun; Fan, Min; Xiang, Jiaqing; Zhang, Yawei; Chen, Haiquan; Jiang, Guoliang | |
刊名 | ONCOTARGETS AND THERAPY
![]() |
2016 | |
卷号 | 9 |
关键词 | esophageal squamous cell carcinoma epidermal growth factor receptor monoclonal antibody nimotuzumab |
ISSN号 | 1178-6930 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4287835 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wang, Chunyu,Fu, Xiaolong,Cai, Xuwei,et al. High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy[J]. ONCOTARGETS AND THERAPY,2016,9. |
APA | Wang, Chunyu.,Fu, Xiaolong.,Cai, Xuwei.,Wu, Xianghua.,Hu, Xichun.,...&Zhao, Kuaile.(2016).High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy.ONCOTARGETS AND THERAPY,9. |
MLA | Wang, Chunyu,et al."High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy".ONCOTARGETS AND THERAPY 9(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论